Anti-IL1B重组抗体|科研级 Canakinumab ( 卡那奴单抗 )-Product Center-Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

Anti-IL1B重组抗体|科研级 Canakinumab ( 卡那奴单抗 )

Detailed related information Target background information Experimental Plan&FAQ Related products Recommended Services

询价与订购

Name*
Phone*
Email*
Product*
Content*

Anti-IL1B重组抗体|科研级 Canakinumab ( 卡那奴单抗 )

instructions Contact

< >

CatNo：TKYR1159

Price

WeChat QR
Contact Us

instructions
MSDSWeChat QR
Contact Us

Detailed

Background

Plan&FAQ

Recommended

Detailed related information

Catalog Number

TKYR1159

Alias

科研级 Canakinumab ( 卡那奴单抗 ), Anti-IL1B Recombinant Antibody, Research Grade Canakinumab

Molecular Name

Canakinumab

Size

1mg, 5mg

CAS Number

914613-48-2

Isotype

IgG1 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Molecular Weight

145.2 kDa

Applications

FC, IP, ELISA, Neut, FuncS, IF, IHC

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Protein Chemical Formula

C6452H9958N1722O2010S42

Target

IL1B[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Canakinumab (INN), sold under the brand name Ilaris is a medication for the treatment of systemic juvenile idiopathic arthritis (SJIA) and active Still's disease, including adult-onset Still's disease (AOSD). It is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivity with other members of the interleukin-1 family, including interleukin-1 alpha.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

Target background information

Experimental Plan&FAQ